Which component is described as the site where the drug binds to initiate the chain of events?

Which component is described as the site where the drug binds to initiate the chain of events?

• A. Membrane transport channel
• B. Cytoplasm
• C. A receptor
• D. The extracellular space

Answer: (C)

Binding to a receptor is how many drugs kick off a cellular response. The receptor is a protein with a specific binding site that, when a drug fits, changes shape and triggers a signaling cascade inside the cell. This conversion of binding into a series of events—often via second messengers or changes in gene expression—constitutes the initiated chain of events. The membrane transport channel is a possible target in some cases, but it isn’t the universal starting point for signaling in pharmacodynamics. The extracellular space is simply the location the drug occupies before binding, not the site that launches the response. The cytoplasm can host intracellular targets, but the initiating site for most drug-induced cascades is the receptor itself.

Binding to a receptor is how many drugs kick off a cellular response. The receptor is a protein with a specific binding site that, when a drug fits, changes shape and triggers a signaling cascade inside the cell. This conversion of binding into a series of events—often via second messengers or changes in gene expression—constitutes the initiated chain of events.

The membrane transport channel is a possible target in some cases, but it isn’t the universal starting point for signaling in pharmacodynamics. The extracellular space is simply the location the drug occupies before binding, not the site that launches the response. The cytoplasm can host intracellular targets, but the initiating site for most drug-induced cascades is the receptor itself.